- 全部删除
- 您的购物车当前为空
HDAC6-IN-55 (Compound 15B) 是一种强效的HDAC6抑制剂,兼具有效的抗炎特性。通过调控TLR4/MAPK、STAT3和NF-κB通路,HDAC6-IN-55 能够缓解特应性皮炎。它在2,4-dinitrochlorobenzene (DNCB) 诱发的特应性皮炎小鼠模型中,减少皮肤水肿、干燥、结痂和脱皮的症状。
HDAC6-IN-55 (Compound 15B) 是一种强效的HDAC6抑制剂,兼具有效的抗炎特性。通过调控TLR4/MAPK、STAT3和NF-κB通路,HDAC6-IN-55 能够缓解特应性皮炎。它在2,4-dinitrochlorobenzene (DNCB) 诱发的特应性皮炎小鼠模型中,减少皮肤水肿、干燥、结痂和脱皮的症状。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
HDAC6-IN-55 相关产品
产品描述 | HDAC6-IN-55 (Compound 15B) is a potent HDAC6 inhibitor and an effective anti-inflammatory agent. It mitigates inflammation through the TLR4/MAPK, STAT3, and NF-κB pathways, providing relief from atopic dermatitis. HDAC6-IN-55 alleviates symptoms such as skin edema, dryness, crusting, and peeling in mice with atopic dermatitis induced by 2,4-dinitrochlorobenzene (DNCB). |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容